{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:41:18Z","timestamp":1793911278742,"version":"4.8.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T00:00:00Z","timestamp":1483488000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Histone acetylation has been linked to cardiac hypertrophy and heart failure. However, the pathological implications of changes in histone methylation and the effects of interventions with histone methyltransferase inhibitors for heart failure have not been fully clarified. Here, we focused on H3K9me3 status in the heart and investigated the effects of the histone H3K9 methyltransferase inhibitor chaetocin on prognoses in Dahl salt-sensitive rats, an animal model of chronic heart failure. Chaetocin prolonged survival and restored mitochondrial dysfunction. ChIP-seq analysis demonstrated that chronic stress to the heart induced H3K9me3 elevation in thousands of repetitive elements, including intronic regions of mitochondria-related genes, such as the gene encoding\n                    <jats:italic>peroxisome proliferator-activated receptor-gamma coactivator 1 alpha<\/jats:italic>\n                    . Furthermore, chaetocin reversed this effect on these repetitive loci. These data suggested that excessive heterochromatinization of repetitive elements of mitochondrial genes in the failing heart may lead to the silencing of genes and impair heart function. Thus, chaetocin may be a potential therapeutic agent for chronic heart failure.\n                  <\/jats:p>","DOI":"10.1038\/srep39752","type":"journal-article","created":{"date-parts":[[2017,1,4]],"date-time":"2017-01-04T05:16:33Z","timestamp":1483506993000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":41,"title":["The histone 3 lysine 9 methyltransferase inhibitor chaetocin improves prognosis in a rat model of high salt diet-induced heart failure"],"prefix":"10.1038","volume":"7","author":[{"given":"Tomohiko","family":"Ono","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kamimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Matsuhashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Hishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Ohta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Suematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ieda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoaki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichi","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruri","family":"Kaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,4]]},"reference":[{"key":"BFsrep39752_CR1","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/j.1751-7133.2012.00292.x","volume":"18","author":"KK Gaddam","year":"2012","unstructured":"Gaddam, K. K. & Ventura, H. Developments in heart failure 2011. Congest Heart Fail 18, 112\u2013126 (2012).","journal-title":"Congest Heart Fail"},{"key":"BFsrep39752_CR2","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1161\/CIRCRESAHA.113.300268","volume":"113","author":"VL Roger","year":"2013","unstructured":"Roger, V. L. Epidemiology of heart failure. Circ Res 113, 646\u2013659 (2013).","journal-title":"Circ Res"},{"key":"BFsrep39752_CR3","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","volume":"334","author":"M Packer","year":"1996","unstructured":"Packer, M. et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med 334, 1349\u20131355 (1996).","journal-title":"N Engl J Med"},{"key":"BFsrep39752_CR4","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","volume":"344","author":"M Packer","year":"2001","unstructured":"Packer, M. et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 344, 1651\u20131658 (2001).","journal-title":"N Engl J Med"},{"key":"BFsrep39752_CR5","doi-asserted-by":"crossref","unstructured":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL randomised intervention trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. Lancet 353, 2001\u20132007 (1999).","DOI":"10.1016\/S0140-6736(99)04440-2"},{"key":"BFsrep39752_CR6","doi-asserted-by":"crossref","unstructured":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group. N Engl J Med 316, 1429\u20131435 (1987).","DOI":"10.1056\/NEJM198706043162301"},{"key":"BFsrep39752_CR7","doi-asserted-by":"crossref","unstructured":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators. N Engl J Med 325, 293\u2013302 (1991).","DOI":"10.1056\/NEJM199108013250501"},{"key":"BFsrep39752_CR8","first-page":"e240","volume":"128","author":"CW Yancy","year":"2013","unstructured":"Yancy, C. W. et al. ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines. Circulation 128, e240\u2013327 (2013).","journal-title":"Circulation"},{"key":"BFsrep39752_CR9","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.jacc.2006.07.026","volume":"48","author":"AS Barth","year":"2006","unstructured":"Barth, A. S. et al. Identification of a common gene expression signature in dilated cardiomyopathy across independent microarray studies. J Am Coll Cardiol 48, 1610\u20131617 (2006).","journal-title":"J Am Coll Cardiol"},{"key":"BFsrep39752_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ygeno.2009.03.003","volume":"94","author":"D Colak","year":"2009","unstructured":"Colak, D. et al. Left ventricular global transcriptional profiling in human end-stage dilated cardiomyopathy. Genomics 94, 20\u201331 (2009).","journal-title":"Genomics"},{"key":"BFsrep39752_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/S0008-6363(03)00426-7","volume":"59","author":"R Grzeskowiak","year":"2003","unstructured":"Grzeskowiak, R. et al. Expression profiling of human idiopathic dilated cardiomyopathy. Cardiovasc Res 59, 400\u2013411 (2003).","journal-title":"Cardiovasc Res"},{"key":"BFsrep39752_CR12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.ygeno.2003.08.007","volume":"83","author":"CK Yung","year":"2004","unstructured":"Yung, C. K., Halperin, V. L., Tomaselli, G. F. & Winslow, R. L. Gene expression profiles in end-stage human idiopathic dilated cardiomyopathy: altered expression of apoptotic and cytoskeletal genes. Genomics 83, 281\u2013297 (2004).","journal-title":"Genomics"},{"key":"BFsrep39752_CR13","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1016\/S0002-9440(10)61153-4","volume":"160","author":"JD Barrans","year":"2002","unstructured":"Barrans, J. D., Allen, P. D., Stamatiou, D., Dzau, V. J. & Liew, C. C. Global gene expression profiling of end-stage dilated cardiomyopathy using a human cardiovascular-based cDNA microarray. Am J Pathol 160, 2035\u20132043 (2002).","journal-title":"Am J Pathol"},{"key":"BFsrep39752_CR14","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1253\/circj.CJ-09-0465","volume":"73","author":"M Asakura","year":"2009","unstructured":"Asakura, M. & Kitakaze, M. Global gene expression profiling in the failing myocardium. Circ J 73, 1568\u20131576 (2009).","journal-title":"Circ J"},{"key":"BFsrep39752_CR15","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1146\/annurev.genet.032608.103928","volume":"43","author":"EI Campos","year":"2009","unstructured":"Campos, E. I. & Reinberg, D. Histones: annotating chromatin. Annu Rev Genet 43, 559\u2013599 (2009).","journal-title":"Annu Rev Genet"},{"key":"BFsrep39752_CR16","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/S0092-8674(02)00861-9","volume":"110","author":"CL Zhang","year":"2002","unstructured":"Zhang, C. L. et al. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110, 479\u2013488 (2002).","journal-title":"Cell"},{"key":"BFsrep39752_CR17","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1161\/CIRCULATIONAHA.107.760488","volume":"118","author":"JQ Wei","year":"2008","unstructured":"Wei, J. Q. et al. Quantitative control of adaptive cardiac hypertrophy by acetyltransferase p300. Circulation 118, 934\u2013946 (2008).","journal-title":"Circulation"},{"key":"BFsrep39752_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/HYPERTENSIONAHA.110.154567","volume":"56","author":"JP Cardinale","year":"2010","unstructured":"Cardinale, J. P. et al. HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats. Hypertension 56, 437\u2013444 (2010).","journal-title":"Hypertension"},{"key":"BFsrep39752_CR19","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1146\/annurev-pharmtox-010611-134712","volume":"52","author":"TA McKinsey","year":"2012","unstructured":"McKinsey, T. A. Therapeutic potential for HDAC inhibitors in the heart. Annu Rev Pharmacol Toxicol 52, 303\u2013319 (2012).","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"BFsrep39752_CR20","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.yjmcc.2009.08.022","volume":"47","author":"HJ Kee","year":"2009","unstructured":"Kee, H. J. & Kook, H. Kruppel-like factor 4 mediates histone deacetylase inhibitor-induced prevention of cardiac hypertrophy. J Mol Cell Cardiol 47, 770\u2013780 (2009).","journal-title":"J Mol Cell Cardiol"},{"key":"BFsrep39752_CR21","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/HYPERTENSIONAHA.108.125088","volume":"53","author":"DJ Glenn","year":"2009","unstructured":"Glenn, D. J., Wang, F., Chen, S., Nishimoto, M. & Gardner, D. G. Endothelin-stimulated human B-type natriuretic peptide gene expression is mediated by Yin Yang 1 in association with histone deacetylase 2. Hypertension 53, 549\u2013555 (2009).","journal-title":"Hypertension"},{"key":"BFsrep39752_CR22","doi-asserted-by":"publisher","first-page":"4123","DOI":"10.1073\/pnas.1015081108","volume":"108","author":"DJ Cao","year":"2011","unstructured":"Cao, D. J. et al. Histone deacetylase (HDAC) inhibitors attenuate cardiac hypertrophy by suppressing autophagy. Proc Natl Acad Sci USA 108, 4123\u20134128 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep39752_CR23","doi-asserted-by":"publisher","first-page":"H2154","DOI":"10.1152\/ajpheart.01015.2009","volume":"298","author":"LX Zhang","year":"2010","unstructured":"Zhang, L. X. et al. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition. Am J Physiol Heart Circ Physiol 298, H2154\u20132163 (2010).","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"BFsrep39752_CR24","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1161\/CIRCULATIONAHA.106.625467","volume":"113","author":"Y Kong","year":"2006","unstructured":"Kong, Y. et al. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy. Circulation 113, 2579\u20132588 (2006).","journal-title":"Circulation"},{"key":"BFsrep39752_CR25","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.matbio.2010.05.002","volume":"29","author":"MJ Barter","year":"2010","unstructured":"Barter, M. J. et al. HDAC-mediated control of ERK- and PI3K-dependent TGF-beta-induced extracellular matrix-regulating genes. Matrix Biol 29, 602\u2013612 (2010).","journal-title":"Matrix Biol"},{"key":"BFsrep39752_CR26","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/j.1476-5381.2010.00637.x","volume":"159","author":"A Iyer","year":"2010","unstructured":"Iyer, A. et al. Antifibrotic activity of an inhibitor of histone deacetylases in DOCA-salt hypertensive rats. Br J Pharmacol 159, 1408\u20131417 (2010).","journal-title":"Br J Pharmacol"},{"key":"BFsrep39752_CR27","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/nm1652","volume":"13","author":"R Tao","year":"2007","unstructured":"Tao, R. et al. Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat Med 13, 1299\u20131307 (2007).","journal-title":"Nat Med"},{"key":"BFsrep39752_CR28","doi-asserted-by":"publisher","first-page":"5567","DOI":"10.1074\/jbc.M110.163865","volume":"286","author":"SA Samant","year":"2011","unstructured":"Samant, S. A. et al. HDAC3-dependent reversible lysine acetylation of cardiac myosin heavy chain isoforms modulates their enzymatic and motor activity. J Biol Chem 286, 5567\u20135577 (2011).","journal-title":"J Biol Chem"},{"key":"BFsrep39752_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1365-2443.2008.01252.x","volume":"14","author":"R Kaneda","year":"2009","unstructured":"Kaneda, R. et al. Genome-wide histone methylation profile for heart failure. Genes Cells 14, 69\u201377 (2009).","journal-title":"Genes Cells"},{"key":"BFsrep39752_CR30","doi-asserted-by":"publisher","first-page":"2411","DOI":"10.1161\/CIRCULATIONAHA.111.040071","volume":"124","author":"M Movassagh","year":"2011","unstructured":"Movassagh, M. et al. Distinct epigenomic features in end-stage failing human hearts. Circulation 124, 2411\u20132422 (2011).","journal-title":"Circulation"},{"key":"BFsrep39752_CR31","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1172\/JCI61084","volume":"123","author":"M Hohl","year":"2013","unstructured":"Hohl, M. et al. HDAC4 controls histone methylation in response to elevated cardiac load. J Clin Invest 123, 1359\u20131370 (2013).","journal-title":"J Clin Invest"},{"key":"BFsrep39752_CR32","doi-asserted-by":"publisher","first-page":"2447","DOI":"10.1172\/JCI46277","volume":"121","author":"QJ Zhang","year":"2011","unstructured":"Zhang, Q. J. et al. The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice. J Clin Invest 121, 2447\u20132456 (2011).","journal-title":"J Clin Invest"},{"key":"BFsrep39752_CR33","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1172\/JCI44641","volume":"121","author":"AB Stein","year":"2011","unstructured":"Stein, A. B. et al. Loss of H3K4 methylation destabilizes gene expression patterns and physiological functions in adult murine cardiomyocytes. J Clin Invest 121, 2641\u20132650 (2011).","journal-title":"J Clin Invest"},{"key":"BFsrep39752_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1093\/emboj\/21.5.1121","volume":"21","author":"G Schotta","year":"2002","unstructured":"Schotta, G. et al. Central role of Drosophila SU(VAR)3-9 in histone H3-K9 methylation and heterochromatic gene silencing. EMBO J 21, 1121\u20131131 (2002).","journal-title":"EMBO J"},{"key":"BFsrep39752_CR35","doi-asserted-by":"publisher","first-page":"3244","DOI":"10.1038\/onc.2011.502","volume":"31","author":"RB Slee","year":"2012","unstructured":"Slee, R. B. et al. Cancer-associated alteration of pericentromeric heterochromatin may contribute to chromosome instability. Oncogene 31, 3244\u20133253 (2012).","journal-title":"Oncogene"},{"key":"BFsrep39752_CR36","doi-asserted-by":"publisher","first-page":"17657","DOI":"10.1073\/pnas.1215810109","volume":"109","author":"RG Hunter","year":"2012","unstructured":"Hunter, R. G. et al. Acute stress and hippocampal histone H3 lysine 9 trimethylation, a retrotransposon silencing response. Proc Natl Acad Sci USA 109, 17657\u201317662 (2012).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep39752_CR37","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1002\/hlca.19700530521","volume":"53","author":"D Hauser","year":"1970","unstructured":"Hauser, D., Weber, H. P. & Sigg, H. P. [Isolation and configuration of Chaetocin]. Helv Chim Acta 53, 1061\u20131073 (1970).","journal-title":"Helv Chim Acta"},{"key":"BFsrep39752_CR38","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nchembio721","volume":"1","author":"D Greiner","year":"2005","unstructured":"Greiner, D., Bonaldi, T., Eskeland, R., Roemer, E. & Imhof, A. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat Chem Biol 1, 143\u2013145 (2005).","journal-title":"Nat Chem Biol"},{"key":"BFsrep39752_CR39","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.1093\/hmg\/ddt115","volume":"22","author":"PK Chan","year":"2013","unstructured":"Chan, P. K. et al. Heterochromatinization induced by GAA-repeat hyperexpansion in Friedreich\u2019s ataxia can be reduced upon HDAC inhibition by vitamin B3. Hum Mol Genet 22, 2662\u20132675 (2013).","journal-title":"Hum Mol Genet"},{"key":"BFsrep39752_CR40","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/ng1294","volume":"36","author":"Y Asano","year":"2004","unstructured":"Asano, Y. et al. Lamr1 functional retroposon causes right ventricular dysplasia in mice. Nat Genet 36, 123\u2013130 (2004).","journal-title":"Nat Genet"},{"key":"BFsrep39752_CR41","doi-asserted-by":"publisher","first-page":"6543","DOI":"10.1073\/pnas.83.17.6543","volume":"83","author":"Y Matsubara","year":"1986","unstructured":"Matsubara, Y. et al. Molecular cloning of cDNAs encoding rat and human medium-chain acyl-CoA dehydrogenase and assignment of the gene to human chromosome 1. Proc Natl Acad Sci USA 83, 6543\u20136547 (1986).","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFsrep39752_CR42","doi-asserted-by":"publisher","first-page":"12381","DOI":"10.1074\/jbc.275.17.12381","volume":"275","author":"T Jonassen","year":"2000","unstructured":"Jonassen, T. & Clarke, C. F. Isolation and functional expression of human COQ3, a gene encoding a methyltransferase required for ubiquinone biosynthesis. J Biol Chem 275, 12381\u201312387 (2000).","journal-title":"J Biol Chem"},{"key":"BFsrep39752_CR43","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0005-2728(02)00270-0","volume":"1555","author":"S Papa","year":"2002","unstructured":"Papa, S. The NDUFS4 nuclear gene of complex I of mitochondria and the cAMP cascade. Biochim Biophys Acta 1555, 147\u2013153 (2002).","journal-title":"Biochim Biophys Acta"},{"key":"BFsrep39752_CR44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nchembio.1187","volume":"9","author":"F Cherblanc","year":"2013","unstructured":"Cherblanc, F., Chapman, K., Brown, R. & Fuchter, M. Chaetocin is a nonspecific inhibitor of histone lysine methyltransferases. Nat Chem Biol 9, 136\u2013137 (2013).","journal-title":"Nat Chem Biol"},{"key":"BFsrep39752_CR45","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/ja.2012.6","volume":"65","author":"M Takahashi","year":"2012","unstructured":"Takahashi, M. et al. Inhibition of histone H3K9 methyltransferases by gliotoxin and related epipolythiodioxopiperazines. J Antibiot 65, 263\u2013265 (2012).","journal-title":"J Antibiot"},{"key":"BFsrep39752_CR46","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1182\/blood-2006-07-027326","volume":"109","author":"CR Isham","year":"2007","unstructured":"Isham, C. R. et al. Chaetocin: a promising new antimyeloma agent with in vitro and in vivo activity mediated via imposition of oxidative stress. Blood 109, 2579\u20132588 (2007).","journal-title":"Blood"},{"key":"BFsrep39752_CR47","doi-asserted-by":"publisher","first-page":"W317","DOI":"10.1093\/nar\/gkp416","volume":"37","author":"R Nogales-Cadenas","year":"2009","unstructured":"Nogales-Cadenas, R. et al. Genecodis: Interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 37, W317\u2013322 (2009).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep39752_CR48","doi-asserted-by":"publisher","first-page":"W478","DOI":"10.1093\/nar\/gks402","volume":"40","author":"D Tabas-Madrid","year":"2012","unstructured":"Tabas-Madrid, D., Nogales-Cadenas, R. & Pascual-Montano, A. Genecodis3: A non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 40, W478\u2013483 (2012).","journal-title":"Nucleic Acids Res"},{"key":"BFsrep39752_CR49","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/gb-2007-8-1-r3","volume":"8","author":"P Carmona-Saez","year":"2007","unstructured":"Carmona-Saez, P., Chagoyen, M., Tirado, F., Carazo, J. M. & Pascual-Montano, A. Genecodis: A web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 8, R3 (2007).","journal-title":"Genome Biol"},{"key":"BFsrep39752_CR50","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1161\/CIRCRESAHA.109.206607","volume":"105","author":"J Endo","year":"2009","unstructured":"Endo, J. et al. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. Circ Res 105, 1118\u20131127 (2009).","journal-title":"Circ Res"},{"key":"BFsrep39752_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jnutbio.2009.01.011","volume":"21","author":"AM Wolf","year":"2010","unstructured":"Wolf, A. M. et al. Astaxanthin protects mitochondrial redox state and functional integrity against oxidative stress. J Nutr Biochem 21, 381\u2013389 (2010).","journal-title":"J Nutr Biochem"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep39752.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39752","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep39752.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:39:29Z","timestamp":1671817169000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep39752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,5,2]]}},"alternative-id":["BFsrep39752"],"URL":"https:\/\/doi.org\/10.1038\/srep39752","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,4]]},"assertion":[{"value":"4 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39752"}}